Tissue eosinophils express the IL-33 receptor ST2 and type 2 cytokines in patients with eosinophilic esophagitis

Allergy. 2022 Feb;77(2):656-660. doi: 10.1111/all.15127. Epub 2021 Oct 11.

Authors

Amiko M Uchida^{1

2

3}, Patrick J Lenehan^{2

3}, Praveen Vimalathas¹, Kaia C Miller¹, Mabel Valencia-Yang¹, Li Qiang^{3

4}, Lauren A Canha¹, Lestat R Ali^{2

3}, Michael Dougan^{1

2

3

4}, John J Garber^{1

2}, Stephanie K Dougan^{3

4}

Affiliations

¹ Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
² Department of Medicine, Harvard Medical School, Boston, MA, USA.
³ Cancer Immunology and Virology, Dana Farber Cancer Institute, Boston, MA, USA.
⁴ Department of Immunology, Harvard Medical School, Boston, MA, USA.

No abstract available

Keywords: clinical immunology; eosinophils; flow cytometry; interleukins; mucosal immunity.

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Cytokines
Enteritis
Eosinophilia
Eosinophilic Esophagitis*
Eosinophils
Gastritis
Humans
Interleukin-1 Receptor-Like 1 Protein*
Interleukin-33

Substances

Cytokines
Interleukin-1 Receptor-Like 1 Protein
Interleukin-33

Supplementary concepts

Eosinophilic enteropathy

Grants and funding